Funding

The Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation (FRFF) receives or has received support from a diverse collective of funding agencies, including, but not limited to, the National Institute of Justice (NIJ) under the U.S. Department of Justice (DOJ), the Centers for Disease Control and Prevention (CDC), the National Institute on Drug Abuse (NIDA) under the National Institutes of Health (NIH) and the U.S. Department of Health and Human Services (DHHS), the Colombo Plan and the U.S. Department of State, and the U.S. Food and Drug Administration (FDA).

The opinions, findings, conclusions and/or recommendations expressed in our publications, presentations, or on our webpages are those of the author(s) and do not necessarily represent the official positions or policies of any funding agency.

For more information about our support and funding, contact our scientists via This email address is being protected from spambots. You need JavaScript enabled to view it.. 

NIJ-FUNDED RESEARCH ON NPS

CFSRE’s NPS Discovery is supported by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice (Award Number 15PNIJ-24-GK-00981-COAP, “Novel Psychoactive Substance Discovery, Education, and Reporting Institute”). The opinions, findings, conclusions and/or recommendations expressed in our publications and presentations are those of the author(s) and do not necessarily represent the official position or policies of the U.S. Department of Justice.

The National Institute of Justice (NIJ) has funded several research projects conducted at the CFSRE since 2013, including awards prior to and including the inception of our NPS Discovery program. The CFSRE would like to express sincere gratitude to the NIJ/DOJ for the many years of funding and interest in our important research.

• 2013 -- Identification and Prevalence Determination of Novel Recreational Drugs and Discovery of their Metabolites in Blood, Urine and Oral Fluid (Award# NIJ-2013-DN-BX-K018, PI Amanda LA Mohr & Barry K Logan)
• 2015 -- Monitoring Changes in the Novel Psychoactive Substance (NPS) Market Through Enhanced Identification of Emerging Drugs and their Metabolites In Biological Samples (Award# NIJ-2015-IJ-CX-K012, PI Amanda LA Mohr & Barry K Logan)
• 2017 -- A More Timely Process for Identifying and Analyzing Trends of Emerging Novel Psychoactive Substances in the United States (Award# 2017-R2-CX-0002, PI Alex J Krotulski, GRF, Temple University)
• 2017 -- Retrospective Identification of Synthetic Cannabinoids in Forensic Toxicology Casework using Archived High Resolution Mass Spectrometry Data (Award# NIJ-2017-R2-CX-0021, PI Amanda LA Mohr & Barry K Logan)
• 2019 -- Toxicological Time Travel: Retrospective Datamining of Analytical Time-of-Flight Mass Spectrometry Data for Evaluating the Rise and Fall of Novel Opioid and Fentanyl Analog Use in the U.S. (Award# NIJ-2017-DN-BX-0169, PI Amanda LA Mohr & Barry K Logan)
• 2020 -- Real-Time Sample-Mining and Data-Mining Approaches for the Discovery of Novel Psychoactive Substances (NPS) (Award# 2020-DQ-BX-0007, PI Alex J Krotulski & Barry K Logan)
• 2022 -- Implementation of NPS Discovery – An Early Warning Systems for Novel Drug Intelligence, Surveillance, Monitoring, Response, and Forecasting using Drug Materials and Toxicology Populations in the US (Award# 15PNIJ-22-GG-04434-MUMU, PI Alex J Krotulski & Barry K Logan)
• 2024 -- Novel Psychoactive Substance Discovery, Education, and Reporting Institute (NPS DiscERn) (Award# 15PNIJ-24-GK-00981-COAP, PI Alex J Krotulski & Barry K Logan)